Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC—a multicenter evaluation (original) (raw)
Multicenter study of Abbott AxSYM® Digoxin II assay and comparison with 6 methods for susceptibility to digoxin-like immunoreactive factors
Hassan Azzazy
Clinical Chemistry, 1997
View PDFchevron_right
A physician's office-based digoxin assay (Seralyzer) evaluated for interference by endogenous digoxin-like immunoreactive factors
Roland Valdes
PubMed, 1989
View PDFchevron_right
Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations
Amitava Dasgupta
American journal of clinical pathology, 1999
View PDFchevron_right
Establishment of a Highly Specific Enzyme Immunoassay for Digoxin in Human Serum
Jacobs Publishers
View PDFchevron_right
Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind®)
Asli Pinar, Roland Valdes
Clinica Chimica Acta, 1999
View PDFchevron_right
A New, High-Throughput HPLC/MS Assay for Therapeutic Level Monitoring of Digoxin in Human Plasma
Daniela-Saveta Popa
View PDFchevron_right
Comparable Effects of DIGIBIND and DigiFab in Thirteen Digoxin Immunoassays
Elizabeth Frank
Clinical Chemistry, 2002
View PDFchevron_right
A Retrospective Analysis about the Quality of Therapeutic Drug Monitoring of Digoxin
FİLİZ ÖZYİGİT
2015
View PDFchevron_right
Therapeutic drug monitoring of digoxin–20 years of experience
Michał Kasprzak
Pharmacological Reports, 2017
View PDFchevron_right
A New, High-Throughput High-Performance Liquid Chromatographic/Mass Spectrometric Assay for Therapeutic Level Monitoring of Digoxin in Human Plasma
dana muntean
Journal of AOAC INTERNATIONAL, 2009
View PDFchevron_right
Endogenous and Exogenous Digoxin-like Immunoreactive Substances Impact on Therapeutic Drug Monitoring of Digoxin
Amitava Dasgupta
American Journal of Clinical Pathology, 2002
View PDFchevron_right
Digoxin immunoassay with cross-reactivity of digoxin metabolites proportional to their biological activity
Roland Valdes
Clinical Chemistry, 1994
View PDFchevron_right
Discordant Results from "Real-World" Patient Samples Assayed for Digoxin
Raymond G Morris
Annals of Pharmacotherapy, 2008
View PDFchevron_right
Monitoring Serum Digoxin Concentrations during Digoxin Immune Fab Therapy
Doyle Cummings
DICP, 1991
View PDFchevron_right
Are immunoassays for digoxin reliable?
C. Lingwood
Clinical Biochemistry, 1984
View PDFchevron_right
Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution
Jeffrey Aronson
British Journal of Clinical Pharmacology, 1977
View PDFchevron_right
Digoxin-Like and Digitoxin-Like Immunoreactive Substances in Elderly People: Impact on Therapeutic Drug Monitoring of Digoxin and Digitoxin Concentrations
Amitava Dasgupta
American Journal of Clinical Pathology, 2001
View PDFchevron_right
Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin
Pradip Datta
Journal of Clinical Laboratory Analysis, 2002
View PDFchevron_right
Determination of Digoxin and Digitoxin in Whole Blood
Elisabeth Øiestad
Journal of Analytical Toxicology, 2009
View PDFchevron_right
Determination of digoxin, digoxigenin and dihydrodigoxigenin in urine by extraction, derivatization and high-performance liquid chromatography
stig waldorff
Journal of chromatography, 1986
View PDFchevron_right
Isolation and characterization of a digoxin-like immunoreactive substance from human urine by affinity chromatography
Claudio Angelis
Clinical chemistry, 1997
View PDFchevron_right
Direct comparison of three methods for predicting digoxin concentrations
James Lane
Pharmacotherapy
View PDFchevron_right
Characterization of Digoxin-Like Materials in Human Cord Serum
Fred Chasalow
Annals of the New York Academy of Sciences, 1990
View PDFchevron_right
High-performance assays of small molecules: enhanced sensitivity, rapidity, and convenience demonstrated with a noncompetitive immunometric anti-immune complex assay system for digoxin
Colin Self
Clinical Chemistry, 1994
View PDFchevron_right
Clinical Consequences of a Miscalibrated Digoxin Immunoassay
Aaron Lim, Raymond G Morris
View PDFchevron_right
Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS/MS method
Nhất Thanh
View PDFchevron_right
Reference Laboratory Values for Digoxin Following Publication of Digitalis Investigation Group (DIG) Trial Data
Mary Mayo
JAMA Internal Medicine, 2013
View PDFchevron_right
Comparison of digoxin concentration in plastic serum tubes with clot activator and heparinized plasma tubes
Lora Dukic
Biochem Med, 2014
View PDFchevron_right
An HPLC method for the determination of digoxin in dissolution samples
Dragan Milenovic
Journal of the Serbian Chemical Society, 2010
View PDFchevron_right
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1)
Geoffrey Isbister
Clinical toxicology (Philadelphia, Pa.), 2016
View PDFchevron_right
Appropriateness of digoxin measurement in hospitalized patients
reyhan uçku
Biochemia Medica, 2017
View PDFchevron_right
Digoxin-like substance in the serum of uremic patients before and after hemodialysis
Zijad Duraković
Cardiovascular Drugs and Therapy, 1989
View PDFchevron_right
Monitoring of Unbound Digoxin in Patients Treated with Anti-Digoxin Antigen-binding Fragments: A Model for the Future?
Roland Valdes
Clinical Chemistry, 1998
View PDFchevron_right
Paradoxical behavior of serum digoxin concentrations in an anuric neonate
George Giacoia
The Journal of Pediatrics, 1977
View PDFchevron_right
A MIP-based flow-through fluoroimmunosensor as an alternative to immunosensors for the determination of digoxin in serum samples
Gema Gonzalez
Analytical and Bioanalytical Chemistry, 2009
View PDFchevron_right